Literature DB >> 10097896

Intensified treatment and education of type 1 diabetes as clinical routine. A nationwide quality-circle experience in Germany. ASD (the Working Group on Structured Diabetes Therapy of the German Diabetes Association).

U A Müller1, M Femerling, K M Reinauer, A Risse, M Voss, V Jörgens, M Berger, I Mühlhauser.   

Abstract

This contribution describes the nationwide implementation of an intensive treatment and education program for type 1 diabetic patients in the clinical routine of the German health care system. Based on the formation of a working group (Arbeitsgemeinschaft Strukturierte Diabetestherapie [ASD]) of presently 57 general internal medicine departments, mainly from secondary and tertiary care levels in city and country hospitals throughout the country, a peer-review quality circle was formed as an official working group of the German Diabetes Association. The participating institutions performed a structured program of intensive treatment and education in all type 1 diabetic patients referred to them on a routine basis. The program includes multiple daily insulin injections or continuous subcutaneous insulin infusion, several times daily blood glucose self-monitoring and self-adaptation of insulin dosages and other aspects of treatment by the patients, and a far-reaching liberalization of the nutrition regimen. The group has attempted to document and to improve the quality of the structure and process of type 1 diabetes care in its participating institutions by a system of peer supervision. Furthermore, all member institutions volunteered to collect outcome data based on systematic 1-1.3 years' follow-up examinations of consecutive type 1 diabetic patients. For the 1997 evaluation of 1,103 type 1 diabetic patients, significant decreases of GHb levels and of incidence rates of severe hypoglycemia (from 0.35 to 0.16 cases per patient-year) and ketoacidosis (from 0.08 to 0.02 cases per patient-year) are presented. The ASD quality circle represents a model to improve principal aspects of type 1 diabetes care on a nationwide basis.

Entities:  

Mesh:

Year:  1999        PMID: 10097896

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  9 in total

1.  Type 1 diabetes: treatment without tears?

Authors:  S A Amiel
Journal:  Diabetologia       Date:  2005-10       Impact factor: 10.122

Review 2.  Meta-analysis does not allow appraisal of complex interventions in diabetes and hypertension self-management: a methodological review.

Authors:  M Lenz; A Steckelberg; B Richter; I Mühlhauser
Journal:  Diabetologia       Date:  2007-05-23       Impact factor: 10.122

3.  [Quality of care of patients with diabetes mellitus living in a rural area of Germany].

Authors:  R Schiel; A Hoffmann; U A Müller
Journal:  Med Klin (Munich)       Date:  1999-03-15

4.  Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study.

Authors:  A Sämann; I Mühlhauser; R Bender; Ch Kloos; U A Müller
Journal:  Diabetologia       Date:  2005-08-18       Impact factor: 10.122

Review 5.  Patient-centered diabetes self-management education.

Authors:  Geoffrey C Williams; Allan Zeldman
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

6.  Higher accuracy of self-monitoring of blood glucose in insulin-treated patients in Germany: clinical and economical aspects.

Authors:  Oliver Schnell; Michael Erbach; Eva Wintergerst
Journal:  J Diabetes Sci Technol       Date:  2013-07-01

7.  Improvement of HbA(1c) and stable weight loss 2 years after an outpatient treatment and teaching program for patients with type 2 diabetes without insulin therapy based on urine glucose self-monitoring.

Authors:  Nicolle Müller; Daniela Stengel; Christof Kloos; Michael Ristow; Gunter Wolf; Ulrich A Müller
Journal:  Int J Gen Med       Date:  2012-03-13

8.  Randomised prospective study for the effect of therapy on residual beta cell function in type-1 diabetes mellitus [ISRCTN70703138].

Authors:  Thomas Linn; Marion Mann; Markus Mann; Reinhard G Bretzel; Rolf H Boedeker
Journal:  BMC Endocr Disord       Date:  2003-12-10       Impact factor: 2.763

9.  Randomized crossover study to examine the necessity of an injection-to-meal interval in patients with type 2 diabetes and human insulin.

Authors:  Nicolle Müller; Thomas Frank; Christof Kloos; Thomas Lehmann; Gunter Wolf; Ulrich Alfons Müller
Journal:  Diabetes Care       Date:  2013-01-22       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.